ciprofloxacin has been researched along with Diseases, Occupational in 13 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ciprofloxacin was used as empirical therapy for peritonitis in patients receiving continuous ambulatory peritoneal dialysis (CAPD) for 26 months, providing an opportunity to study the epidemiology of ciprofloxacin resistance amongst coagulase-negative staphylococci (CNS)." | 3.68 | The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients. ( Cookson, BD; Dryden, MS; McCann, M; Phillips, I; Talsania, H, 1992) |
| "Despite its excellent antimicrobial activity against salmonellae and its favorable pharmacokinetic profile, ciprofloxacin at a dosage of 750 mg orally twice daily had an unacceptably high failure rate in patients with acute salmonellosis and may have prolonged fecal excretion of salmonellae." | 2.67 | Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers. ( Cassidy, JE; Giusti, R; Heelan, J; Mayer, KH; Neill, MA; Opal, SM; White, R, 1991) |
| "Tularemia is a zoonotic disease caused by Francisella tularensis." | 2.45 | Tularemic meningitis in the United States. ( Cardona, L; Davis, LE; Hofinger, DM; Mertz, GJ, 2009) |
| " This report updates the investigation of these cases and describes adverse events associated with antimicrobial prophylaxis." | 1.31 | Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis. ( , 2001) |
| " During October 26-November 6, 2001, an epidemiologic evaluation to detect adverse events associated with antimicrobial prophylaxis was conducted among 8,424 postal employees who had been offered antimicrobial prophylaxis for 60 days in New Jersey (NJ), New York City (NYC), and one postal facility in the District of Columbia (DC)." | 1.31 | Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001. ( , 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 9 (69.23) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pradhan, S | 1 |
| Uddaraju, M | 1 |
| Mascarenhas, J | 1 |
| Hofinger, DM | 1 |
| Cardona, L | 1 |
| Mertz, GJ | 1 |
| Davis, LE | 1 |
| Yetkin, MA | 1 |
| Erdinc, FS | 1 |
| Bulut, C | 1 |
| Tulek, N | 1 |
| Stevens, JP | 1 |
| Daniel, TM | 1 |
| Eaton, L | 1 |
| Charatan, F | 1 |
| Salavert, M | 1 |
| Navarro, V | 1 |
| Roig, P | 1 |
| Dryden, MS | 1 |
| Talsania, H | 1 |
| McCann, M | 1 |
| Cookson, BD | 1 |
| Phillips, I | 1 |
| Neill, MA | 1 |
| Opal, SM | 1 |
| Heelan, J | 1 |
| Giusti, R | 1 |
| Cassidy, JE | 1 |
| White, R | 1 |
| Mayer, KH | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Natural History of Anthrax: A Study of Primary Infected, Recovered, and Exposed (SPoRE) Individuals and Evaluation of AVA Vaccinated Recipients[NCT00050310] | 200 participants (Anticipated) | Observational | 2002-10-31 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ciprofloxacin and Diseases, Occupational
| Article | Year |
|---|---|
Tularemic meningitis in the United States.
Topics: Administration, Oral; Adult; Chloramphenicol; Ciprofloxacin; Diagnosis, Differential; Drug Therapy, | 2009 |
[Purulent pericarditis due to Salmonella enterica subsp. arizonae].
Topics: Amikacin; Animals; Animals, Domestic; Atrial Fibrillation; Cefuroxime; Ciprofloxacin; Combined Modal | 2002 |
1 trial available for ciprofloxacin and Diseases, Occupational
| Article | Year |
|---|---|
Failure of ciprofloxacin to eradicate convalescent fecal excretion after acute salmonellosis: experience during an outbreak in health care workers.
Topics: Acute Disease; Adult; Carrier State; Ciprofloxacin; Convalescence; Disease Outbreaks; Double-Blind M | 1991 |
10 other studies available for ciprofloxacin and Diseases, Occupational
| Article | Year |
|---|---|
Unusual course of microsporidial keratoconjunctivitis as an occupational hazard in a veterinary physician.
Topics: Adult; Animals; Anti-Bacterial Agents; Antifungal Agents; Ciprofloxacin; Drug Therapy, Combination; | 2016 |
Cutaneous anthrax as an occupational disease in Central Anatolia, Turkey.
Topics: Adolescent; Adult; Agriculture; Animals; Anthrax; Anti-Bacterial Agents; Anti-Infective Agents; Baci | 2006 |
Chemoprophylaxis of multidrug-resistant tuberculous infection in HIV-uninfected individuals using ciprofloxacin and pyrazinamide. A decision analysis.
Topics: Adult; Ciprofloxacin; Decision Support Techniques; Decision Trees; Health Personnel; HIV Seronegativ | 1995 |
UK doctors given guidance on dealing with anthrax.
Topics: Abattoirs; Anthrax; Anthrax Vaccines; Anti-Infective Agents; Ciprofloxacin; Health Personnel; Humans | 2001 |
Anthrax blamed as two postal workers die in United States.
Topics: Anthrax; Anti-Infective Agents; Bioterrorism; Ciprofloxacin; Humans; Male; Occupational Diseases; Po | 2001 |
Update: Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
From the Centers for Disease Control and Prevention. Investigation of bioterrorism-related anthrax and adverse events from antimicrobial prophylaxis.
Topics: Anthrax; Anti-Infective Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
From the Centers for Disease Control and Prevention. Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
Topics: Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
Update: adverse events associated with anthrax prophylaxis among postal employees--New Jersey, New York City, and the District of Columbia metropolitan area, 2001.
Topics: Anthrax; Anti-Bacterial Agents; Antibiotic Prophylaxis; Bacillus anthracis; Bioterrorism; Ciprofloxa | 2001 |
The epidemiology of ciprofloxacin resistance in coagulase-negative staphylococci in CAPD patients.
Topics: Air Microbiology; Carrier State; Ciprofloxacin; Cross Infection; Drug Resistance, Microbial; Health | 1992 |